These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Immunohistochemical analysis of normal and mutated ras oncogene p21 expression in human pulmonary and pleural neoplasms. Radosevich JA, Gould VE, Ma Y, Lee I, Thor A, Carney WP, Warren WH, Schlom J, Rosen ST. Virchows Arch B Cell Pathol Incl Mol Pathol; 1989; 56(6):377-83. PubMed ID: 2567085 [Abstract] [Full Text] [Related]
3. Expression of the epitope recognized by the monoclonal antibody 44-3A6 during human fetal development. Radosevich JA, Combs SG, Rosen ST. Tumour Biol; 1991; 12(6):321-9. PubMed ID: 1724706 [Abstract] [Full Text] [Related]
4. Comparative immunohistochemical reactivity of monoclonal and polyclonal antibodies to H-ras p21 in normal and neoplastic tissues of rodents and humans. Ward JM, Perantoni AO, Santos E. Oncogene; 1989 Feb; 4(2):203-13. PubMed ID: 2648257 [Abstract] [Full Text] [Related]
5. Enhanced expression of c-Ha-ras p21 in human stomach adenocarcinomas defined by immunoassays using monoclonal antibodies and in situ hybridization. Ohuchi N, Hand PH, Merlo G, Fujita J, Mariani-Costantini R, Thor A, Nose M, Callahan R, Schlom J. Cancer Res; 1987 Mar 01; 47(5):1413-20. PubMed ID: 2434216 [Abstract] [Full Text] [Related]
6. Immunolocalization of ras oncogene p21 in human liver diseases. Radosevich JA, Gould KA, Koukoulis GK, Haines GK, Rosen ST, Lee I, Gould VE. Ultrastruct Pathol; 1993 Mar 01; 17(1):1-8. PubMed ID: 8381245 [Abstract] [Full Text] [Related]
7. Immunohistochemical demonstration of ras p21 oncogene product in normal, benign, and malignant human thyroid tissues. Mizukami Y, Nonomura A, Hashimoto T, Terahata S, Matsubara F, Michigishi T, Noguchi M. Cancer; 1988 Mar 01; 61(5):873-80. PubMed ID: 3276392 [Abstract] [Full Text] [Related]
8. Optimal preservation of p21 ras immunoreactivity and morphology in paraffin-embedded tissue. Going JJ, Williams AR, Wyllie AH, Anderson TJ, Piris J. J Pathol; 1988 Jul 01; 155(3):185-90. PubMed ID: 3045276 [Abstract] [Full Text] [Related]
9. ras p21 oncoprotein expression in human colonic neoplasia--an immunohistochemical study with monoclonal antibody RAP-5. Lanza G. Histopathology; 1988 Jun 01; 12(6):595-609. PubMed ID: 3047043 [Abstract] [Full Text] [Related]
10. Reported binding of monoclonal antibody RAP-5 to formalin-fixed tissue sections is not indicative of ras p21 expression. Samowitz WS, Paull G, Hamilton SR. Hum Pathol; 1988 Feb 01; 19(2):127-32. PubMed ID: 2449385 [Abstract] [Full Text] [Related]
11. Expression of ras and myc oncogenes in human hepatocellular carcinoma and non-neoplastic liver tissues. Tiniakos D, Spandidos DA, Kakkanas A, Pintzas A, Pollice L, Tiniakos G. Anticancer Res; 1989 Feb 01; 9(3):715-21. PubMed ID: 2548435 [Abstract] [Full Text] [Related]
12. Expression of the 21,000 molecular weight ras protein in a spectrum of benign and malignant human mammary tissues. Ohuchi N, Thor A, Page DL, Hand PH, Halter SA, Schlom J. Cancer Res; 1986 May 01; 46(5):2511-9. PubMed ID: 3084069 [Abstract] [Full Text] [Related]
13. Activated Val-12 ras p21 in cell culture fluids and mouse plasma. Hamer PJ, La Vecchio J, Ng S, DeLellis R, Wolfe H, Carney WP. Oncogene; 1991 Sep 01; 6(9):1609-15. PubMed ID: 1923528 [Abstract] [Full Text] [Related]
15. Immunohistochemical and immunoblot analyses of ras-p21 expression in lung carcinomas. Koshiishi Y, Noguchi M, Nakajima T, Hirohashi S, Shimosato Y, Hayata Y. Acta Pathol Jpn; 1989 Oct 01; 39(10):643-7. PubMed ID: 2686349 [Abstract] [Full Text] [Related]
16. Inhibition of yeast adenylate cyclase by antibodies to ras p21. Gibbs JB, Marsico-Ahern JD, Scolnick EM, Sigal IS. Biochem J; 1988 May 15; 252(1):289-92. PubMed ID: 2458712 [Abstract] [Full Text] [Related]